RU2008142704A - METHOD FOR TREATING RADIATING DISEASE OF SERVICE DOGS AND METHOD FOR PREVENTING RADIATING DISEASE OF SERVICE DOGS - Google Patents
METHOD FOR TREATING RADIATING DISEASE OF SERVICE DOGS AND METHOD FOR PREVENTING RADIATING DISEASE OF SERVICE DOGS Download PDFInfo
- Publication number
- RU2008142704A RU2008142704A RU2008142704/13A RU2008142704A RU2008142704A RU 2008142704 A RU2008142704 A RU 2008142704A RU 2008142704/13 A RU2008142704/13 A RU 2008142704/13A RU 2008142704 A RU2008142704 A RU 2008142704A RU 2008142704 A RU2008142704 A RU 2008142704A
- Authority
- RU
- Russia
- Prior art keywords
- dogs
- solution
- collargol
- dose
- injected
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Способ лечения лучевой болезни служебных собак, включающий введение в организм колларгола и общеукрепляющих средств, отличающийся тем, что через 2 ч после облучения собакам вводят колларгол на 0,5%-ном официнальном растворе новокаина внутрилегочно в виде 1%-ного раствора в дозе 1-3 мг/кг, а через 15, 24 и 48 ч после облучения колларгол на 0,5%-ном официнальном растворе новокаина вводят подкожно в виде 0,5%-ного раствора в дозе 3-5 мг/кг массы тела, при этом с 1 по 25-е сутки собакам также ежедневно вводят в качестве общеукрепляющих средств аскорбиновую кислоту и 1%-ный раствор викасола по 1 мл, фитохитодез-02 и мумие по 5 таблеток на собаку, а с 5-х суток после облучения собакам дополнительно вводят 3%-ный раствор байтрила в дозе 3 мл. ! 2. Способ лечения лучевой болезни служебных собак по п.1, отличающийся тем, что при повышении температуры тела собакам дополнительно вводят стрептомицин и бензилпенициллина натриевую соль 1 г и 1000000 ЕД соответственно на собаку, 3 раза в сутки, каждые 7-8 ч. ! 2. Способ профилактики лучевой болезни служебных собак, включающий введение в организм колларгола и общеукрепляющих средств, отличающийся тем, что за 1, 3 и 5 суток до облучения собакам вводят внутрилегочно колларгол на 0,5%-ном официнальном растворе новокаина в виде 1%-ного раствора в дозе 3-5 мг/кг массы тела, а в качестве общеукрепляющих средств собакам вводят аскорбиновую кислоту и 1%-ный раствор викасола по 1 мл, фитохитодез-02 и мумие по 5 таблеток на собаку, при этом с 5-х суток после облучения собакам дополнительно вводят 3%-ный раствор байтрила в дозе 3 мл. 1. A method of treating radiation sickness of service dogs, comprising introducing collargol and restorative agents into the body, characterized in that 2 hours after irradiation, dogs are injected with collargol in a 0.5% official solution of novocaine intrapulmonary in the form of a 1% solution in a dose 1-3 mg / kg, and after 15, 24 and 48 hours after irradiation, collargol in a 0.5% official solution of novocaine is administered subcutaneously in the form of a 0.5% solution at a dose of 3-5 mg / kg body weight, at the same time, from the 1st to the 25th day, the dogs are also daily injected with ascorbic acid as general strengthening agents slot and 1% vicasol solution 1 ml each, phytochitodes-02 and mummy 5 tablets per dog, and from the 5th day after irradiation, dogs are additionally given a 3% solution of baytril in a dose of 3 ml. ! 2. A method of treating radiation sickness of service dogs according to claim 1, characterized in that, with an increase in body temperature, dogs are additionally injected with streptomycin and benzylpenicillin sodium salt 1 g and 1,000,000 units, respectively, per dog, 3 times a day, every 7-8 hours! 2. A method for the prevention of radiation sickness of service dogs, including the introduction of collargol and general restorative agents into the body, characterized in that 1, 3 and 5 days prior to irradiation, dogs are administered intragulmonary collargol in a 0.5% official solution of novocaine in the form of 1% - solution in a dose of 3-5 mg / kg body weight, and as general strengthening agents, dogs are injected with ascorbic acid and 1% Vikasol solution 1 ml each, phytochitodez-02 and mummy 5 tablets per dog, with 5 days after exposure, dogs are additionally injected with a 3% solution of baytril at a dose of 3 ml.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008142704/13A RU2391967C1 (en) | 2008-10-29 | 2008-10-29 | Method of radiation sickness treatment in utility dogs and method of radiation sickness preventing in utility dogs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008142704/13A RU2391967C1 (en) | 2008-10-29 | 2008-10-29 | Method of radiation sickness treatment in utility dogs and method of radiation sickness preventing in utility dogs |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2008142704A true RU2008142704A (en) | 2010-05-10 |
RU2391967C1 RU2391967C1 (en) | 2010-06-20 |
Family
ID=42673372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008142704/13A RU2391967C1 (en) | 2008-10-29 | 2008-10-29 | Method of radiation sickness treatment in utility dogs and method of radiation sickness preventing in utility dogs |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2391967C1 (en) |
-
2008
- 2008-10-29 RU RU2008142704/13A patent/RU2391967C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2391967C1 (en) | 2010-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2012118974A (en) | COMBINATIONS OF PI3K INHIBITOR AND MEK INHIBITOR | |
RU2015127794A (en) | Introduction of antisense oligonucleotides complementary to human apolipoprotein B | |
RU2011102797A (en) | ANTI-TUMOR COMBINATIONS OF 4-ANILINO-3-CYANOCHINOLINS AND CAPETSITABINE | |
CN107669692B (en) | Application of MPLA in preparation of medicines for preventing and treating intestinal injury caused by ionizing radiation | |
RU2012108439A (en) | METHODS FOR TREATING TUMORS OF THE BRAIN | |
TNSN07474A1 (en) | Dosage regimen for prasugrel | |
ES2755303T3 (en) | Medicinal composition to enhance the synthesis of protoporphyrin IX | |
CN1795003A (en) | Anti-inflammatory composition based on strontium compounds | |
RU2007139540A (en) | COMBINED THERAPY FOR CANCER TREATMENT | |
RU2008142704A (en) | METHOD FOR TREATING RADIATING DISEASE OF SERVICE DOGS AND METHOD FOR PREVENTING RADIATING DISEASE OF SERVICE DOGS | |
US20200289425A1 (en) | Carbon dot liposomes and uses thereof | |
RU2005132175A (en) | COMBINED TREATMENT OF TUMORS, INCLUDING NEMORUBICINS AND RADIATION THERAPY | |
CA2481005C (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy | |
RU2010139840A (en) | COMBINATION OF ANTI-CANCER AGENTS | |
RU2013142014A (en) | GAMMA SECRETASE INHIBITOR METHOD | |
JP2005509663A5 (en) | ||
JPH0432052B2 (en) | ||
RU2010134265A (en) | METHOD FOR TREATING DYSPEPSY IN CALVES | |
CN103169716A (en) | Compound medicinal composition for treating pain | |
CN103181906A (en) | Itraconazole flavoured tablet for pets and preparation method for the same | |
RU2008150401A (en) | METHOD FOR TREATING BABESIOSIS OF DOGS | |
RU2008120401A (en) | COMBINATION OF HISTONDEACETYLASE AND RADIATION INHIBITORS | |
RU2023446C1 (en) | Antimetastatic drug | |
RU2007100833A (en) | METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD | |
RU2135178C1 (en) | Method of increasing antitumor efficiency in experiment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20101030 |